tern-701 - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,841 +0.86%

DJIA 48,348 +0.92%

Nasdaq 25,099 +0.82%

DAX 23,937 -0.11%

Gold $4,196 +0.16%

Oil $95.76 -0.96%

BTC $72,438 +1.50%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

S&P 500 6,841 +0.86%

DJIA 48,348 +0.92%

Nasdaq 25,099 +0.82%

DAX 23,937 -0.11%

Gold $4,196 +0.16%

Oil $95.76 -0.96%

BTC $72,438 +1.50%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

tern-701

Merck Terns Acquisition visualized with premium TERN-701 oncology drug concept

Pharma & Healthcare·Stocks·USA

Merck Terns Acquisition $6.7B Surge as Keytruda Cliff Nears

By Maik Kemper • Mar 25, 2026

Merck Terns Acquisition visualized with premium TERN-701 oncology drug concept

Pharma & Healthcare·Stocks·USA

Merck Terns Acquisition $6.7B Surge as Keytruda Cliff Nears

By Maik Kemper • Mar 25, 2026

Can the Merck Terns Acquisition really plug the looming Keytruda revenue gap or is $6.7 billion just a high-risk oncology bet? Maik Kemper Editor in…